Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 338

recruiting
3 975
countries
28
conditions
2 109

10 388 trials match your criteria

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Dermatitis atopic

Not yet recruiting

Study of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Colorectal adenocarcinoma

Not yet recruiting

A Phase 2 Study of VS-7375 Alone or with Drug Combination in Patients with Metastatic KRAS G12D‑Mutated Colorectal Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years

C3 glomerulopathy

Not yet recruiting

Pegcetacoplan to Prevent Recurrence of C3 Glomerulopathy or Primary Immune‑Complex MPGN in Adolescent and Adult Kidney Transplant Recipients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years

Partial seizures

Not yet recruiting

One-Year Open-Label Extension Study Evaluating Safety and Efficacy of Huperzine A as Adjunctive Therapy in Adults with Focal Onset Seizures

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years

Colorectal cancer

Not yet recruiting

A phase 1/2 study evaluating safety, pharmacokinetics and efficacy of SOT109 in patients with advanced unresectable or metastatic colorectal cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years

Renal transplant

Not yet recruiting

Study of anti‑T lymphocyte immunoglobulin (rabbit) in non‑sensitized kidney transplant recipients at high risk of delayed graft function

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years

Prostate cancer

Not yet recruiting

Evaluation of [99mTc]PSMA I&S PET‑Guided Navigation with Electromagnetic Tracking in miN1 Prostate Cancer Patients Undergoing Radio‑Guided Surgery

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:[99MTC]PSMA I&S
Countries:GreeceGreece
  • Participants:0–17 years · Healthy volunteers
  • Substances:Clesrovimab
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.